|
MAN2A2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.300100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.949540E-02 |
| Normal-vs-Stage2 |
1.172160E-01 |
| Normal-vs-Stage3 |
9.396700E-04 |
| Normal-vs-Stage4 |
1.376130E-02 |
| Stage1-vs-Stage2 |
8.315000E-01 |
| Stage1-vs-Stage3 |
1.139190E-01 |
| Stage1-vs-Stage4 |
5.578200E-01 |
| Stage2-vs-Stage3 |
2.243800E-01 |
| Stage2-vs-Stage4 |
5.508200E-01 |
| Stage3-vs-Stage4 |
5.710000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.359600E-03 |
| Normal-vs-AfricanAmerican |
4.314600E-01 |
| Normal-vs-Asian |
4.099700E-02 |
| Caucasian-vs-AfricanAmerican |
2.716000E-01 |
| Caucasian-vs-Asian |
6.392600E-01 |
| AfricanAmerican-vs-Asian |
4.097800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.066300E-02 |
| Normal-vs-Female |
5.838500E-03 |
| Male-vs-Female |
7.089200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.046240E-02 |
| Normal-vs-Age(41-60Yrs) |
8.703600E-03 |
| Normal-vs-Age(61-80Yrs) |
5.453900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.879900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.386400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.446800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.072020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.313600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.409810E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.004750E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.62619999999936E-05 |
| Classical-VS-Follicular |
7.736200E-01 |
| Classical-VS-Other |
4.592600E-01 |
| Classical-VS-Normal |
3.418400E-02 |
| Tall-VS-Follicular |
1.700660E-03 |
| Tall-VS-Other |
2.586600E-01 |
| Tall-VS-Normal |
1.69719999998375E-06 |
| Follicular-VS-Other |
5.782800E-01 |
| Follicular-VS-Normal |
4.261600E-02 |
| Other-VS-Normal |
8.421900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.904400E-03 |
| Normal-vs-N1 |
1.986410E-02 |
| N0-vs-N1 |
7.315400E-01 |
|
|
